2028년까지 아시아 태평양 방사성의약품 시장 예측 – 유형(진단 핵의학 및 치료 핵의학), 애플리케이션(종양학, 심장학, 신경학 및 기타) 및 최종 사용자(병원, 영상 센터, 학술 및 기타)별 코로나19 영향 및 지역 분석 연구센터 등)

시장 소개

APAC는 중국, 일본, 인도, 호주, 한국 등 5개 주요 국가로 구성됩니다. 시장은 아시아 태평양 지역의 나머지 국가에 대해서도 평가됩니다. 예측 기간 동안 일본이 시장을 주도했습니다. 최근 몇 년 동안 일본은 핵의학 분야에 중점을 두고 있습니다. 일본은 노인 인구가 가장 빠르게 증가하는 시대에 진입했습니다. 인구 고령화는 의료 시스템의 변화를 가져왔습니다. 예를 들어, 세계경제포럼(WEF)에 따르면 현재 일본에는 70대 인구가 23억 명에 달합니다. 국가에서 발전된 의료 전환이 나타나고 있으며 의료 시스템의 지속 가능성에 점점 더 큰 압력을 가하고 있습니다. 노인 인구의 증가는 지역의 질병 부담을 증가시키는 원인이 됩니다. 방사성의약품 제조에는 정부기관과 연구기관이 참여하고 있다. 예를 들어, 국립방사선과학원 방사성의약품개발과는 임상진단과 치료에 유용한 방사성의약품 개발, 의약품 합성에 필요한 새로운 방사성핵종 개발, 라벨링 기술 제조 등을 목표로 하고 있다. 신흥 국가의 급격한 성장과 맞춤형 치료를 위한 핵의약품 사용 증가는 APAC 방사성 의약품 시장의 성장을 이끄는 주요 요인입니다.

COVID-19의 경우 APAC, 특히 인도가 큰 영향을 받습니다. 이 지역의 의료 관행은 계속해서 코로나19의 어려움에 적응하고 있습니다. 한편으로는 의료 전문가들이 팬데믹에 대응하고 있고, 다른 한편으로는 코로나19와 관련되지 않은 절차와 입원에 대한 혼란을 최소화하고 있습니다. 전 세계적으로 병원 및 기타 의료 시설에서는 수술과 같은 선택적 절차를 연기해야 합니다. 대부분의 비긴급 치료는 연기되었습니다. 코로나19 팬데믹은 의료 시설로의 일반 환자 흐름을 방해하고, 의료 자원에 스트레스를 주고, 압도하는 것부터 시작해 추가 보호 조치와 사회적 거리 두기의 활용 증가로 이어지는 등 다양한 측면에서 의료 서비스에 영향을 미쳤습니다. 원격 의료 및 가상 의학. 예방적 접근 방식으로 종양학 진료에서는 외래 진료소의 환자 수를 줄이고, 불필요하거나 선택적 절차를 줄이고, 환자를 입원환자 서비스에서 퇴원시키기 위한 구체적인 조치를 시행했습니다. 이는 이 지역 방사성 의약품 시장의 성장에 부정적인 영향을 미쳤습니다. 또한 시장 참여자들도 공급망 반대자들과 수요 감소로 인해 전염병의 영향을 받았습니다. 특수 의약품 부문, 특히 방사성 의약품은 코로나19와 방사성 의약품 경쟁으로 인해 영향을 받았습니다. 팬데믹 이전에도 핵의학 공급망은 원자재 가용성, 제조 시설 운영 및 항공 운송 신뢰성에 따라 매우 복잡했습니다. 따라서 위에 언급된 요인들은 이 지역의 방사성 의약품 시장에 부정적인 영향을 미치고 있습니다.

시장 개요 및 역학

APAC 방사성 의약품 시장은 2021년 13억 8,459만 달러에서 2028년 26억 6,138만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 9.8%로 성장할 것으로 추정됩니다. 표적 알파 요법(TAT)은 국소 및 전신 암 치료에 사용되는 최신의 진화하는 기술입니다. 전임상 연구와 임상 시험을 통해 알파 방출 방사성 핵종은 표적 암세포를 죽이고 건강한 세포에는 해를 끼치지 않는다는 것이 입증되었습니다(선택적 세포 독성). 211At, 213Bi, 225Ac 및 227Th는 단일클론 항체와 같은 표적화 벡터를 표지하는 데 사용되는 알파 방출 방사성 동위원소 중 하나입니다. α-방출 방사성 핵종으로 표지된 단일클론 항체가 효과적인 방사성면역요법으로 떠오르고 있습니다. 단거리 방사성 동위원소(α 입자)는 혈액암 환자 치료에 사용됩니다. 알파 방사선은 혈관 및 림프계에서 분리된 암세포를 죽이는 데 적합할 뿐만 아니라 종양 모세혈관 내피 세포(EC)를 표적으로 삼아 죽이기 위해 종양 모세혈관 네트워크를 방해하여 종양을 퇴행시키는 데에도 적합합니다. 라듐-223 이염화물 알파 요법은 내부 알파 방출 방사성 동위원소 암 치료에 대해 유일하게 승인된 개념입니다. 악성 조직에 도달한 후 방사성 원소가 붕괴되면 인접한 건강한 조직에 심각한 손상을 주지 않고 종양을 파괴하는 방사선이 방출됩니다. 알파 방사선은 매우 국지적이며 최대 2~10개의 세포층을 관통합니다. 주변 조직의 건강한 세포는 방사선으로 인한 손상으로부터 어느 정도 스스로 회복할 수 있습니다. 핵 영상화는 수명이 긴 감마 방출체를 사용합니다. 이는 시간이 지남에 따라 종양이 접합체의 흡수를 증가시켜 혈액 제거를 허용하여 대비를 향상시킵니다. 핵영상검사를 통해 종양과 장기를 진단할 수 있습니다. 또한, 알파 방사선면역요법에 대한 인식이 높아지고 암 치료 절차에 대한 치료법이 급증하면서 핵영상 촬영에 대한 수요가 늘어나고 있습니다. 따라서 암 치료에서 알파 방사선면역요법의 선호되는 사용은 APAC 방사성 의약품 시장 성장을 촉진하고 있습니다.

주요 시장 부문

유형 면에서 진단 핵의학 부문은 2020년 APAC 방사성 의약품 시장에서 가장 큰 점유율을 차지했습니다. 적용 측면에서 종양학 부문은 2020년 APAC 방사성 의약품 시장에서 더 큰 시장 점유율을 차지했습니다. 2020. 또한 병원 부문은 2020년 최종 사용자를 기준으로 APAC 방사성 의약품 시장에서 더 큰 점유율을 차지했습니다.

주요 출처 및 회사 목록

APAC 방사성 의약품 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Advanced Accelerator Application입니다. 바이엘 AG; 브라코 이미징 SpA; 추기경 건강 Inc; 큐륨; ECZACIBA?I MONROL 원자력 제품 CO.; 일반 전기; Lantheus Medical Imaging, Inc.; 노르디온; 및 NTP RADIOISOTOPES.

구매 이유 보고서

APAC 방사성 의약품 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별
APAC 방사성 의약품 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 APAC 방사성 의약품 시장에서 M&A 및 파트너십 거래를 효율적으로 계획합니다.
다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다. APAC 방사성 의약품 시장 형성
2021~2028년 APAC 지역의 다양한 부문별 시장 수익 예측을 얻습니다.

APAC 방사성 의약품 시장 세분화

APAC 방사성 의약품 시장 - 유형별

핵의학 진단
- SPECT
- PET
치료용 핵의학
- 알파 방사체
- 베타 방사체
- 근접 치료 동위원소

< p>APAC 방사성 의약품 시장 - 용도별

종양학
심장학
신경학
기타

APAC 방사성 의약품 시장 - 최종 사용자별

병원
영상 센터
학술 및 연구 센터 ;
기타

APAC 방사성 의약품 시장 - 국가별

APAC 방사성 의약품 시장 - 회사 프로필

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Radiopharmaceuticals Market – By Type

1.3.2 APAC Radiopharmaceuticals Market – By Application

1.3.3 APAC Radiopharmaceuticals Market – By End User

1.3.4 APAC Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2 Escalating Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Presence of Alternatives

5.3 Market Opportunities

5.3.1 Soaring Growth in Emerging Countries

5.4 Future Trends

5.4.1 Rising Use of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– APAC Analysis

6.1 APAC Radiopharmaceuticals Market Revenue Forecast and Analysis

7. APAC Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Radiopharmaceuticals Market – Country Analysis

10.1 APAC: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of APAC: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on APAC Radiopharmaceuticals Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bracco Imaging S.p.A

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Nordion

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 NTP RADIOISOTOPES

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Advanced Accelerator Applications

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of APAC: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Recent Inorganic Growth Strategies

Table 33. Recent Organic Growth Strategies

Table 34. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Radiopharmaceuticals Market Segmentation

Figure 2. APAC Radiopharmaceuticals Market Segmentation, By Country

Figure 3. APAC Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. APAC Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. APAC Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. APAC SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. APAC Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. APAC Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. APAC Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample